针对促性腺激素释放激素(GnRH)的新型单剂疫苗候选物在小鼠中的评价
研究在小鼠中评价靶向GnRH的单剂免疫避孕疫苗,比较L15/Quil A、PMA、AddaVax®、IFA与CFA等佐剂系统,并比较含牛兼容辅助T细胞表位与含PADRE表位的构建体。结果显示L15/Quil A疫苗系统高度免疫原性,性能与CFA相当且无需反应原性分枝杆菌成分;疫苗显著降低小鼠血清孕酮水平。
要点
- L15/Quil A单剂GnRH疫苗在小鼠中高度免疫原性,性能与CFA相当。
- 疫苗显著降低小鼠血清孕酮水平。
- L15/Quil A是单剂抗生育应用的强候选,其次为PMA和AddaVax®佐剂GnRH。
核心结论
- L15/Quil A疫苗系统是单剂抗生育应用的强候选,其次为PMA和AddaVax®佐剂GnRH。
研究设计与样本
- 研究在小鼠中评价靶向GnRH的单剂免疫避孕疫苗候选物,比较不同佐剂系统并与CFA对照。
- 疫苗经皮下途径给予C57BL/6小鼠,采用血清学检测评价免疫原性。
- 研究比较含三种牛兼容辅助T细胞表位的构建体与含通用小鼠兼容PADRE(P)辅助T细胞表位的构建体。
主要发现
- L15/Quil A为基础的疫苗系统高度免疫原性,性能与CFA相当且无需反应原性分枝杆菌成分。
- 疫苗显著降低小鼠血清孕酮水平。
- 单剂抗生育应用候选排序为L15/Quil A系统、PMA、AddaVax®佐剂GnRH。
关键数值与推荐
- L15/Quil A疫苗系统免疫原性性能与CFA相当。
- 疫苗显著降低小鼠血清孕酮水平。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Immunocontraceptive vaccines targeting gonadotropin-releasing hormone (GnRH) are in high demand for controlling population growth and managing the temperament of both wild and domesticated animals. Achieving adequate efficacy, especially with a single-dose immunization, requires potent vaccines and adjuvants. However, commercial vaccines face challenges: some, like Gonacon®, have regulatory issues with veterinary authorities, while others, like Bopriva®, lack potency and require multiple booster doses. Thus, there is a critical need for highly effective vaccines with robust adjuvants suitable for easy, less invasive single-dose administration. Recent studies have shown that peptide vaccines adjuvanted with 15-mer polyleucine (L15) or poly(methyl acrylate) (PMA) demonstrate potent immunogenicity, comparable to complete Freund's adjuvant (CFA), after a single dose against Streptococcus pyogenes. Our research aims to evaluate the performance of these promising vaccine adjuvant as single-dose contraceptive vaccines in mice, compared to well-established commercial and experimental adjuvants, such as AddaVax®, Incomplete Freunds Adjuvant (IFA), and CFA. To develop a vaccine with sufficient HLA coverage for cattle immunocontraception, we evaluated a peptide vaccine incorporating three cattle-compatible helper T cell epitopes. We evaluated the immunogenicity of constructs in mice to that of a construct with the universal mouse-compatible PADRE (P) helper T cell epitope. Various vaccines were prepared to investigate: (A) the impact of incorporating cattle-compatible helper T cells on immunogenicity, and (B) the effectiveness of different adjuvant systems compared to CFA. The vaccines were administered subcutaneously to C57BL/6 mice, and serological assays revealed that the L15/Quil A-based vaccine system was highly immunogenic, with performance comparable to CFA without the need for reactogenic mycobacterial components. Our vaccines significantly reduced serum progesterone levels in mice, making the L15/Quil A system a strong candidate for single-dose anti-fertility application, followed by PMA, and AddaVax® adjuvanted GnRH.
引用
- Shalash AO, Wang W, Xia Y, et al. Evaluation of novel single-dose vaccine candidates against gonadotropin-releasing hormone (GnRH) in mice. Vaccine. 2025. PMID: 40186995. doi:10.1016/j.vaccine.2025.127092
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。